These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 17409901)
1. Decreased immunoreactivity of CD99 is an independent predictor of regional lymph node metastases in pulmonary carcinoid tumors. Pelosi G; Leon ME; Veronesi G; Spaggiari L; Pasini F; Viale G J Thorac Oncol; 2006 Jun; 1(5):468-77. PubMed ID: 17409901 [TBL] [Abstract][Full Text] [Related]
2. Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids. Pelosi G; Pasini F; Fraggetta F; Pastorino U; Iannucci A; Maisonneuve P; Arrigoni G; De Manzoni G; Bresaola E; Viale G Lung Cancer; 2003 Nov; 42(2):203-13. PubMed ID: 14568688 [TBL] [Abstract][Full Text] [Related]
3. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207 [TBL] [Abstract][Full Text] [Related]
5. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung. Coppola D; Clarke M; Landreneau R; Weyant RJ; Cooper D; Yousem SA Mod Pathol; 1996 May; 9(5):484-90. PubMed ID: 8733762 [TBL] [Abstract][Full Text] [Related]
6. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922 [TBL] [Abstract][Full Text] [Related]
7. CK19 and CD99 immunoexpression profile in goblet cell (mucin-producing neuroendocrine tumors) and classical carcinoids of the vermiform appendix. Alsaad KO; Serra S; Perren A; Hsieh E; Chetty R Int J Surg Pathol; 2007 Jul; 15(3):252-7. PubMed ID: 17652531 [TBL] [Abstract][Full Text] [Related]
8. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung. Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Iijima H; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M Pathol Res Pract; 2008; 204(8):553-61. PubMed ID: 18440724 [TBL] [Abstract][Full Text] [Related]
9. Typical and atypical pulmonary carcinoids : outcome in patients presenting with regional lymph node involvement. Thomas CF; Tazelaar HD; Jett JR Chest; 2001 Apr; 119(4):1143-50. PubMed ID: 11296182 [TBL] [Abstract][Full Text] [Related]
10. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment]. Langfort R; Rudziński P; Burakowska B Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517 [TBL] [Abstract][Full Text] [Related]
11. CD99 expression in Merkel cell carcinoma: a case series with an unusual paranuclear dot-like staining pattern. Rajagopalan A; Browning D; Salama S J Cutan Pathol; 2013 Jan; 40(1):19-24. PubMed ID: 23145531 [TBL] [Abstract][Full Text] [Related]
13. Molecular markers help characterize neuroendocrine lung tumors. Rusch VW; Klimstra DS; Venkatraman ES Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011 [TBL] [Abstract][Full Text] [Related]
14. PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors. Long KB; Srivastava A; Hirsch MS; Hornick JL Am J Surg Pathol; 2010 May; 34(5):723-9. PubMed ID: 20414099 [TBL] [Abstract][Full Text] [Related]
15. CD117 immunoreactivity in high-grade neuroendocrine tumors of the lung: a comparative study of 39 large-cell neuroendocrine carcinomas and 27 surgically resected small-cell carcinomas. Pelosi G; Masullo M; Leon ME; Veronesi G; Spaggiari L; Pasini F; Sonzogni A; Iannucci A; Bresaola E; Viale G Virchows Arch; 2004 Nov; 445(5):449-55. PubMed ID: 15375659 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of CD99 protein expression in pancreatic endocrine tumours (PETs). Goto A; Niki T; Terado Y; Fukushima J; Fukayama M Histopathology; 2004 Oct; 45(4):384-92. PubMed ID: 15469477 [TBL] [Abstract][Full Text] [Related]
17. [Typical and atypical pulmonary carcinoids--pathologic and clinical analysis of 77 cases]. Słodkowska J; Langfort R; Rudziński P; Kupis W Pneumonol Alergol Pol; 1998; 66(5-6):297-303. PubMed ID: 9857650 [TBL] [Abstract][Full Text] [Related]
18. Altered expression of microRNA miR-21, miR-155, and let-7a and their roles in pulmonary neuroendocrine tumors. Lee HW; Lee EH; Ha SY; Lee CH; Chang HK; Chang S; Kwon KY; Hwang IS; Roh MS; Seo JW Pathol Int; 2012 Sep; 62(9):583-91. PubMed ID: 22924844 [TBL] [Abstract][Full Text] [Related]
19. Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung. Dosaka-Akita H; Cagle PT; Hiroumi H; Fujita M; Yamashita M; Sharma A; Kawakami Y; Benedict WF Cancer; 2000 Feb; 88(3):550-6. PubMed ID: 10649246 [TBL] [Abstract][Full Text] [Related]
20. Incidence and Prognostic Significance of Carcinoid Lymph Node Metastases. Kneuertz PJ; Kamel MK; Stiles BM; Lee BE; Rahouma M; Harrison SW; Altorki NK; Port JL Ann Thorac Surg; 2018 Oct; 106(4):981-988. PubMed ID: 29908980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]